Cerebras targets £85-£93 ($115-$125) IPO share price, valuing chipmaker at £29bn

TL;DR:

• AI chipmaker Cerebras Systems will start its IPO roadshow on Monday at a target share price of £85-£93 ($115-$125), aiming to raise up to £2.9bn ($4bn) at a valuation around £29bn ($40bn).
• It is Cerebras’s second IPO attempt after withdrawing a previous filing in October 2025; the company will list on Nasdaq under “CBRS”.
• Revenue jumped to £376m ($510m) in the year ended December, from £214m ($290m) a year earlier; the firm reported a £1.02 ($1.38) per-share profit, reversing a £7.31 ($9.90) per-share loss.

The Sunnyvale-based company makes wafer-scale-engine chips that compete with Nvidia GPUs for AI training and inference workloads. Lead underwriters are Morgan Stanley, Citigroup, Barclays and UBS — a syndicate weighted toward firms with strong UK institutional desks.

Context

Cerebras’s pricing arrives during the most concentrated AI infrastructure capital markets activity of the past three years. Bloomberg’s Q1 earnings analysis published yesterday showed the Magnificent Seven on track for 57% Q1 earnings growth, with Alphabet up 23% YTD on AI infrastructure strength while Meta is down 7.8% on capex concerns. The Philadelphia Stock Exchange Semiconductor Index closed at a fresh record on Friday, up 50% YTD. Cerebras is pricing into a market that is rewarding capacity-providing firms (chips, cloud) over capex-heavy general platform builders.

The first IPO attempt failed in October 2025 amid CFIUS scrutiny over Saudi-linked customer concentration. The current filing reflects a different revenue profile and customer mix; the absolute scale of the revenue jump — roughly 76% year-over-year — and the swing to profitability are the headline financial signals. The wafer-scale architecture, which puts an entire AI accelerator on a single silicon die rather than networking many chips together, is differentiated rather than commodity, which limits direct comparison with Nvidia GPUs but supports a sustainability-of-margin thesis.

For UK institutional investors, the Cerebras pricing is a calibration point on AI infrastructure value. UK pension funds and asset managers have been overweight Nvidia for two years; whether allocators see Cerebras as a hedge against Nvidia concentration risk, or as a riskier secondary play, will affect demand in the European book.

Looking forward

The roadshow runs through this week and pricing should land in mid-to-late May. UK institutional appetite for AI hardware names beyond Nvidia is the practical test. If Cerebras prices toward the top of its range, the read-across is that allocators are actively diversifying. If it prices below the range or pulls again, the message is that Nvidia remains the only credible AI chip story for institutional money — a dynamic with implications for UK firms procuring AI compute capacity.